Δευτέρα 28 Νοεμβρίου 2016

Immunological Risk Stratification by Assessing both the HLA and non-HLA Specific Antibodies: Time to Include Testing for Non-HLA Antibodies in the Routine Clinical Antibody Analysis Profile?.

wk-health-logo.gif

No abstract available

http://ift.tt/2gQZAwJ

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου